PEAK6 Investments’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$356K Buy
+12,600
New +$325K ﹤0.01% 2508
2023
Q1
Sell
-8,500
Closed -$239K 4469
2022
Q4
$239K Buy
+8,500
New +$244K ﹤0.01% 3154
2022
Q2
Sell
-33,400
Closed -$1.08M 6202
2022
Q1
$1.08M Buy
+33,400
New +$874K ﹤0.01% 2425
2021
Q2
Sell
-21,500
Closed -$434K 5294
2021
Q1
$434K Buy
+21,500
New +$409K ﹤0.01% 3341

Other funds holding EVH

PEAK6 Investments's EVH Position: Q3 2024 in Review

PEAK6 Investments opened a new position in Evolent Health (EVH) in Q3 2024: 12,649 shares worth $358K. The stake represents ﹤0.01% of the portfolio and ranks #2505 among its holdings. This is a return to the name: PEAK6 Investments previously reported a position in EVH as recently as Q4 2022.

PEAK6 Investments first reported a position in EVH in Q1 2021 and has held it in 4 quarters since. 262 funds tracked by Wall St. Rank hold EVH as of Q3 2024.

  • PEAK6 Investments held 12,649 shares of Evolent Health worth $358K as of Q3 2024.
  • Evolent Health was a new PEAK6 Investments position in Q3 2024.
  • Evolent Health made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2505 holding.
  • PEAK6 Investments first reported a position in Evolent Health in Q1 2021 and has held it in 4 quarters since.
  • 262 funds tracked by Wall St. Rank held Evolent Health as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.